AGL · agilon health, inc.
$82.28
+2.69 (+3.38%)
At close · Oct 1
Return incl. dividend (before tax)
Market Cap
$1.37B
Shares
16.79M
Volume · Oct 1
262.29K
Avg daily vol (3M)
294.06K
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$82.28
Open$79.35
Day$77.71–83.94
52W close$7.91–129.84
Avg vol 30d221K
Short int1.1M · 6.3% float · 6.2d
Short vol73%
Last earningsAug 5, 2026
DataApr 2021–Oct 2026
Filing10-Q · Aug 5
Up next
Next earnings call
Nov 5, 2026
Est · unconfirmed
· in 5 wks
filed Aug 5, 2026
call held Aug 5, 2026
Metrics snapshot
Useful current figures from the complete screener profile.
Revenue (TTM)
$5.92B
Trailing 12 months
Net income (TTM)
−$232.22M
Trailing 12 months
Revenue growth YoY
+7.2%
Year over year
Operating margin
-5.2%
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
-6.2%
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+4.0%
Year over year · more shares
Price change (1Y)
—
Trailing year
Short interest
6.3%
Latest settlement · 6.2 days to cover
Equibles Rating
blended score · not investment adviceOverall
Neutral
SellHoldBuy
Technical
Neutral
Momentum
Strong
Sentiment
Bullish
Fundamentals
Weak
Quant / Vol
Very High
Market backdrop
VIX 16.4 · calm
Equity put/call 0.57
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+42%
above
Price vs 50-day avg
−10%
below
RSI (14)
43
neutral
MACD trend
Negative
52-week position
61%
mid-range
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
−6%
trailing
6-month return
+333%
trailing
YTD return
+378%
this year
Relative strength
+320%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $91 › 200d $58 — 50d above 200d
Institutional flow
Accumulating
+80% holders QoQ · +92 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
6.26% of float · ▼ -2.8% MoM · 6.2 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
180 holders — mid 3-yr range
Squeeze score
53
elevated · 0–100
Fundamentals
Revenue growth
−2%
Y/Y
Free cash flow
$-119.0M
Balance sheet
$138.7M
net cash
Quant / Vol
risk profile
Volatility
168%
annualized · 1-yr
Max drawdown
−72%
past year
ATR
7.2%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Latest guidance
· from the Earnings Call filed Jun 30, 2026
full year 2026
Revenue
Initiated
$5.8B
prior FY $5.93B
midpoint −2.2% Y/Y
Adjusted EBITDA
Non-GAAP
Initiated
$85M
ACO reach adjusted EBITDA
Non-GAAP
Initiated
$25M – $30M
third quarter
Revenue
$1.46B
prior qtr $1.49B
midpoint −2.3% QoQ
Medical margin
$110M
year-end 2026
Year-end cash
at least $125M
Prior guidance
period ended
· from the Earnings Call filed Jun 30, 2026
Cost trend
· full year 2025
5.8%
Cost trend
· first quarter 2026
6%
Guided vs delivered
· last 3 settled
Revenue
full year 2021
guided $1.82B – $1.83B
$1.52B
Miss −16.5%
Revenue
third quarter 2021
guided $450M – $453M
$458.61M
Beat +1.6%
Revenue
second quarter of 2021
guided $470M – $475M
$498.96M
Beat +5.6%
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Neutral
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+42%
Bullish
Price vs 50-day avg
−10%
Bearish
RSI (14)
43
Neutral
MACD trend
Negative
Bearish
52-week position
61%
Neutral
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross)
No cross
50d $91 › 200d $58 — 50d above 200d
Institutional flow
Accumulating
+80% holders QoQ · +92 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
6.26% of float · ▼ -2.8% MoM · 6.2 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
180 holders — mid 3-yr range
Price context
position in its 52-week range
Range low $8
Now $82 · 61%
Range high $130
vs 200-day avg +42%
vs 50-day avg -10%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
Earlier KPI extraction records exist, but do not meet the current evidence-completeness requirements. No current verified series is available. Earlier figures remain withheld until revalidated; this is not evidence that the company reports no KPIs.
Versus peers
Medical Care Facilities — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
AGL
this stock
agilon health, inc.
|
$1.37B | — | -2.1% | — | 6.3% |
|
HCA
HCA Healthcare, Inc.
|
$96.64B | -9.3% | +7.1% | 15.0 | 2.9% |
|
FSNUY
Fresenius SE & Co. KGaA
|
$29.92B | -13.1% | — | — | 0.0% |
|
THC
Tenet Healthcare Corp
|
$20.91B | +27.8% | +0.9% | 10.0 | 2.5% |
|
EHC
Encompass Health Corp
|
$12.18B | +12.2% | +10.5% | 20.1 | 3.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| AGL | +8.5% | -5.8% | +332.6% | +3.4% | +377.7% |
| SPY | -0.4% | -0.2% | +12.4% | +0.2% | +12.0% |
| vs SPY | +8.9% | -5.7% | +320.2% | +3.2% | +365.6% |